Influx Healthtech Ltd
Incorporated in 2020, Influx Healthtech Ltd is a CDMO which deals in nutraceuticals, Ready-to-Drink (RTD) beverages, functional nutrition and pet care.[1]
- Market Cap ₹ 625 Cr.
- Current Price ₹ 270
- High / Low ₹ 315 / 166
- Stock P/E 30.4
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Part of Nifty SME Emerge
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2026 | |
|---|---|
| 147 | |
| 117 | |
| Operating Profit | 30 |
| OPM % | 20% |
| 1 | |
| Interest | 0 |
| Depreciation | 4 |
| Profit before tax | 27 |
| Tax % | 25% |
| 21 | |
| EPS in Rs | 8.87 |
| Dividend Payout % | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 56% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2026 | |
|---|---|
| Equity Capital | |
| Reserves | |
| Total Liabilities | |
| CWIP | |
| Investments | |
| Total Assets |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2026 | |
|---|---|
| 4 | |
| -25 | |
| 45 | |
| Net Cash Flow | 23 |
| Free Cash Flow | -21 |
| CFO/OP | 41% |
Ratios
Consolidated / View Standalone
| Mar 2026 | |
|---|---|
| Debtor Days | |
| Inventory Days | |
| Days Payable | |
| Cash Conversion Cycle | |
| Working Capital Days | |
| ROCE % |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Installed Capacity - Cosmetics & Ayurvedic kg per day |
|
|||
| Installed Capacity - Nutraceuticals kg per day |
||||
| Installed Capacity - Pet Supplements & Homecare kg per day |
||||
| Number of Clients count |
||||
| Number of Products (SKUs) count |
||||
| Top 10 Client Revenue Concentration % |
||||
| Capacity Utilization - Nutraceuticals % |
||||
| Number of Export Countries count |
||||
| Number of Manufacturing Units count |
||||
Extracted by Screener AI
Documents
Announcements
-
Trading Window
- Trading window closed from October 1, 2026 until 48 hours after half-year results.
-
General Updates
- NSE levies Rs. 1.82 lakh fine for 31-day delay in March 31, 2026 consolidated results.
-
Analysts/Institutional Investor Meet/Con. Call Updates
- Influx Healthtech to attend Rising Stars by Arihant Capital investor conference on September 25, 2026, virtually.
-
Shareholders meeting
- 6th AGM voting results released on September 19, 2026; 2 resolutions passed, including Whole-time Director re-appointment.
-
Shareholders meeting
- Influx Healthtech held its 6th AGM on September 18, 2026; audited FY26 results adopted and Shirin Chandniwala reappointed.
Concalls
-
May 2026Transcript PPT REC
-
Nov 2025Transcript PPT REC
-
Aug 2025PPT
Business Overview:[1]
a) IHTL is a contract development and manufacturing organization (CDMO) specializing in nutraceuticals, cosmetics, pet care, and home care
b) The company has approx. 3,400+ products across dietary & nutritional supplements, cosmetics, ayurvedic/herbal formulations, veterinary feed supplements, and homecare solutions
c) It operates a comprehensive business model; provides end-to-end services,
spanning product development, manufacturing, and regulatory support, enabling clients to focus on core areas like formulation, discovery, and commercialization